XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Accounts Receivable, net
9 Months Ended
Mar. 31, 2021
Accounts Receivable, net  
Accounts Receivable, net

Note 5. Accounts Receivable, net

Accounts receivable, net consisted of the following components at March 31, 2021 and June 30, 2020:

March 31, 

    

June 30, 

(In thousands)

    

2021

    

2020

Gross accounts receivable

$

258,652

$

271,557

Less: Chargebacks reserve

 

(74,729)

 

(61,877)

Less: Rebates reserve

 

(16,446)

 

(24,536)

Less: Returns reserve

 

(38,708)

 

(40,796)

Less: Other deductions

 

(13,449)

 

(17,557)

Less: Allowance for doubtful accounts

 

(629)

 

(1,103)

Accounts receivable, net

$

114,691

$

125,688

For the three months ended March 31, 2021, the Company recorded a provision for chargebacks, rebates (including rebates presented as rebates payable), returns and other deductions of $135.4 million, $27.1 million, $3.9 million and $18.6 million, respectively. For the three months ended March 31, 2020, the Company recorded a provision for chargebacks, rebates (including rebates presented as rebates payable), returns and other deductions of $201.0 million, $63.8 million, $6.4 million and $35.7 million, respectively.

For the nine months ended March 31, 2021, the Company recorded a provision for chargebacks, rebates (including rebates presented as rebates payable), returns and other deductions of $515.2 million, $104.8 million, $14.5 million and $55.2 million, respectively. For the nine months ended March 31, 2020, the Company recorded a provision for chargebacks, rebates (including rebates presented as rebates payable), returns and other deductions of $608.6 million, $180.6 million, $16.6 million and $77.2 million, respectively.

The following table identifies the activity and ending balances of each major category of revenue-related reserve for the nine months ended March 31, 2021 and 2020:

Reserve Category

(In thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Other

    

Total

Balance at June 30, 2020

$

61,877

$

62,711

$

40,796

$

17,557

$

182,941

Current period provision

 

515,196

 

104,795

 

14,545

 

55,213

 

689,749

Credits issued during the period

 

(502,344)

 

(119,212)

 

(16,633)

 

(59,321)

 

(697,510)

Balance at March 31, 2021

 

$

74,729

 

$

48,294

 

$

38,708

 

$

13,449

 

$

175,180

Reserve Category

(In thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Other

    

Total

Balance at June 30, 2019

$

89,567

$

78,274

$

55,554

$

18,128

$

241,523

Current period provision

 

608,570

 

180,574

 

16,600

 

77,167

 

882,911

Credits issued during the period

 

(637,664)

 

(181,465)

 

(24,466)

 

(52,508)

 

(896,103)

Balance at March 31, 2020

 

$

60,473

 

$

77,383

 

$

47,688

 

$

42,787

 

$

228,331

For the three months ending March 31, 2021 and 2020, as a percentage of gross sales the provision for chargebacks was 46.1% and 45.1%, the provision for rebates was 9.2% and 14.3%, the provision for returns was 1.3% and 1.4% and the provision for other adjustments was 6.3% and 8.0%, respectively.

For the nine months ending March 31, 2021 and 2020, as a percentage of gross sales the provision for chargebacks was 49.2% and 47.8%, the provision for rebates was 10.0% and 14.2%, the provision for returns was 1.4% and 1.3% and the provision for other adjustments was 5.3% and 6.1%, respectively.

The increase in the chargebacks reserve was primarily due to timing of sales and product mix partially offset by lower sales. The rebates reserve decreased primarily due to lower sales of Fluphenazine in Fiscal 2021, which had higher than average government-related rebates. Historically, we have not recorded any material amounts in the current period related to reversals or additions of prior period reserves.